... Cohort 5) to evaluate a single infusion of Sangamo's novel ZFP Therapeutic(A ), SB-728-T, for the treatment of HIV/AIDS. The data demonstrate functional control of the virus at or below the limit of detection in CCR5 delta-32 heterozygote ...
http://www.sbwire.com/press-releases/traders-stocks-alerts-nq-mobile-inc-adr-nysenq-gol-linhas-aereas-inteligentes-sa-adr-nysegol-sangamo-biosciences-inc-nasdaqsgmo-gold-resource-corporation-nyseamexgoro-331684.htm
http://www.sbwire.com/press-releases/traders-stocks-alerts-nq-mobile-inc-adr-nysenq-gol-linhas-aereas-inteligentes-sa-adr-nysegol-sangamo-biosciences-inc-nasdaqsgmo-gold-resource-corporation-nyseamexgoro-331684.htm
No comments:
Post a Comment